Olaregen Therapeutix
New York, US · Founded 2017
Biotech
Founders & leadership
SE
Scott EmmensExecutive Officer
WR
Wesley RamjeetExecutive Officer, Director
AD
Anthony DolisiExecutive Officer
Reported raises · per SEC filings
Form D private placements$450KraisedSep 2018 · 1 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.